glp-1 medical Medications | Fact Sheets and stomach upset GLP-1 Medications for Weight Loss:

If you are curious about what those first weeks feel like, the initial experience on semaglutide varies considerably from person to person, though most people notice appetite suppression within the first one to two weeks

Clinical trials show semaglutide and tirzepatide both have favorable safety profiles when dosed and monitored appropriately, with side effects generally manageable and dose-dependent

Wegovy, which contains semaglutide as its active ingredient, is specifically designed for chronic weight management

These symptoms almost always resolve by day seven at the new dose

This is one of the most common questions women ask, and the honest answer is that we do not have enough data for a definitive comparison